BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Alector

Alector logo

Founded
2013
Geography
United States of America based
Funding
$194.500 M

Alector is a hypothesis-driven, neurology-focused startup that’s pioneering the discovery and development of first-in-class, immuno-modulatory therapies for Alzheimer’s disease and other neurodegenerative disorders. We are combining state-of-the-art antibody technology and recent discoveries in neuro-immunology and human genetics to develop a broad platform of novel therapeutics that harness the immune system to fight dementia and neurodegeneration.

Technologies

Pharmaceutical and Drug Discovery  

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet